Cargando…
CNDP2 Acts as an Activator for Human Ovarian Cancer Growth and Metastasis via the PI3K/AKT Pathway
INTRODUCTION: The mechanism of tumorigenesis and metastasis of ovarian cancer has not yet been elucidated. This study aimed to investigate the role and molecular mechanism of cytosolic nonspecific dipeptidase 2 in tumorigenesis and metastasis. METHODS: Cytosolic nonspecific dipeptidase 2 expression...
Autores principales: | Zhang, Li Q., Yang, Hua Q., Yang, Su Q., Wang, Ying, Chen, Xian J., Lu, Hong S., Zhao, Ling P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755628/ https://www.ncbi.nlm.nih.gov/pubmed/31537175 http://dx.doi.org/10.1177/1533033819874773 |
Ejemplares similares
-
MicroRNA-101 inhibits growth and metastasis of human ovarian cancer cells by targeting PI3K/AKT
por: Wei, Min, et al.
Publicado: (2019) -
BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway
por: Li, X, et al.
Publicado: (2013) -
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway [Corrigendum]
por: Feng, Z, et al.
Publicado: (2019) -
SNCG promotes the progression and metastasis of high-grade serous ovarian cancer via targeting the PI3K/AKT signaling pathway
por: Zhang, Jing, et al.
Publicado: (2020) -
Up-regulation of CNDP2 facilitates the proliferation of colon cancer
por: Xue, Conglong, et al.
Publicado: (2014)